Financial Results
Full Year 2024 – Coming soon!
We will announce our Full Year 2024 results on February 26, 2025. The conference call will take place at 1:30 pm (CET). Please find the dial-in details below.
Our quiet period will start from February 5 to February 25. We will be back on February 26 with all relevant documents to present our financial results, business updates and more.

FY/24 Results
WebcastDocuments
Aide Memoire Q4/24 (PDF)Selected Key Figures Q3/2024
GROUP REVENUE
€ 5305 m
+ 9% 1
Q3/23: €4,967 m
GROUP EBIT 2
€ 552 m
+9% 3
Q3/23: €509 m
NET INCOME 2, 4, 5
€ 312 m
+7% 3
Q3/23: €292 m
EPS 2, 4, 5
€ 0.55
+7% 3
Q3/23: €0.51
1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
2 Before special items
3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation
4 Net income attributable to shareholders of Fresenius SE & Co. KGaA
5 Excluding Fresenius Medical Care
Revenue by business segment
€ in millions | Q3/24 | Q3/23 | Growth at actual rates | Growth at constant rates | Organic growth1 | Acquisitions/Divestitures | % of total revenue |
---|---|---|---|---|---|---|---|
Fresenius Kabi | 2,114 | 2,021 | 5% | 10% | 11% | -1% | 40% |
Fresenius Helios | 3,082 | 2,863 | 8% | 8% | 8% | 0% | 58% |
Total | 5,303 | 4,967 | 7% | 9% | 9% | 0% | 100%2 |
-
1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
2 Remaining 2% Corporate/Other revenue
Before special items